JAN 18, 2020 8:22 PM PST

Drug Combo Targets Osteoarthritis

WRITTEN BY: Nouran Amin

Individuals suffering from osteoarthritis often face challenges of limited treatment options mainly pain relievers or joint replacement surgery. However, scientists using rat models have recently discovered a powerful drug combination that can reverse the cellular and molecular signs of osteoarthritis. The effects of these drugs were also demonstrated in isolated human cartilage cells.

Findings were published in the journal Protein & Cell.

"What's really exciting is that this is potentially a therapy that can be translated to the clinic quite easily," says Juan Carlos Izpisua Belmonte, lead author and a professor in Salk's Gene Expression Laboratory. "We are excited to continue refining this promising combination therapy for human use."

Osteoarthritis is caused by changes in the bone and cartilage cells and is the most common joint disorder and currently affects 30 million adults—it is expected that the disease will rise as a result of the aging population and the increasing rate of obesity. Aging and repeated stress can cause molecules and genes in the cells of articular cartilage to eventually breakdown leading to pain and stiffness.

Learn more about osteoarthritis:

Old studies have confirmed two major drugs that can treat osteoarthritis--alpha-KLOTHO and TGF beta receptor 2 (TGFβR2). These drugs support the growth and strength of articular cartilage cells when worked together as opposed to used alone in treatment. When add as therapeutic combo, they are most effective.

"We thought that by mixing these two molecules that work in different ways, maybe we could make something better," says Paloma Martinez-Redondo, a Salk postdoctoral fellow and co-first author of the new study.

The rats used in the study carried viral particles that enclosed DNA instructions for making αKLOTHO and TGFβR2.

"From the very first time we tested this drug combination on just a few animals, we saw a huge improvement," says Isabel Guillen-Guillen, the paper's co-first author. "We kept checking more animals and seeing the same encouraging results."

In the cartilage cells, experiments confirmed 136 genes that were more active and 18 genes that were less active.

"That's not the same as showing how these drugs affect the knee joint in humans, but we think it's a good sign that this could potentially work for patients," says Martinez-Redondo.

"We think that this could be a viable treatment for osteoarthritis in humans," says Pedro Guillen, director of the Clinica CEMTRO and co-corresponding author.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 20, 2019
Genetics & Genomics
DEC 20, 2019
Can We Cure Down's Syndrome with Gene Therapy?
Down’s Syndrome (DS) is a genetic disorder brought on by the presence of all of part of a third copy of chromosome 21. Linked to delays in physical g...
DEC 22, 2019
Genetics & Genomics
DEC 22, 2019
New Gene Therapy Uses Exosomes to Reverse Disease
Researchers at Ohio State University have developed a new gene therapy that makes use of exosomes, fluid sacs released in cells, to carry therapeutic tools...
DEC 19, 2019
Technology
DEC 19, 2019
Can a 'Lemon' help develop new drugs?
Although artificial intelligence has many advantages in the drug discovery process, challenges still remain--one being the ability for machine learning to ...
DEC 23, 2019
Drug Discovery & Development
DEC 23, 2019
FDA Approves New Schizophrenic Drug
The US Food and Drug Administration (FDA) has approved an atypical antipsychotic Caplyta (lumateperone; Intra-Cellular Therapies) for the treating schizoph...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s...
FEB 10, 2020
Cardiology
FEB 10, 2020
Blocking Problem Protein Shows Promise for Preventing Heart Attacks
Over time, atherosclerosis, a disease that causes fatty plaques to build up in the arteries, limits the flow of oxygen-rich blood to vital organs. Often le...
Loading Comments...